期刊文献+

Correlations between Mitofusin 2 Expression in Fibroblasts and Pelvic Organ Prolapse: An In vitro Study 被引量:4

Correlations between Mitofusin 2 Expression in Fibroblasts and Pelvic Organ Prolapse: An In vitro Study
原文传递
导出
摘要 Background:Both Mitofusin 2 (Mfn2) and pelvic organ prolapse (POP) are related to aging.The aim of the present study was to investigate the variations of Mfn2 expression in the uterosacral ligaments of patients with and/or without POP and their correlations with the expression of procollagen.Methods:Fibroblasts were cultured using tissue specimens that were harvested from the uterosacral ligaments of POP and non-POP (NPOP) patients (n =10 for each group) from September 2016 to December 2016.The Cell Counting Kit-8 (CCK-8) assay was used to compare the differences in cell proliferation between the two groups.Relative quantitative reverse transcription-polymerase chain reaction and Western blotting assays were employed to assess the differences in the mRNA and protein expression levels of Mfn2 and procollagen 1A1/1A2/3A1 between the two groups.The changes in procollagen expression were assessed following the downregulation of Mfn2 in the POP group using RNAi.The data were assessed with independent sample t-test or general linear model univariate analysis using the SPSS 13.0 software.Results:The results from CCK-8 assay indicated that cell viability in the POP group was significantly lower compared with that of the NPOP group (td5,7,9,11=-5.925,-6.851,-9.129,and-9.661,respectively,all P 〈 0.001,from D5 to D 11).The mRNA and protein expression levels of Mfn2 in the cultured fibroblasts of the POP group were significantly higher compared with those of the NPOP group (mRNA:t =2.425,P =0.032;protein:t =2.392,P =0.037,respectively),whereas only the expression levels of procollagen 1A1/1A2/3A1 were significantly higher in the NPOP group (mRNA:t =-2.165,P1A1 =0.041;t =-2.741,P1A2 =0.026;t =-2.147,P3A1 =0.045,respectively;protein:t =-2.418,P1A1 =0.029;t =-2.405,P1A2 =0.033;t =-2.470,P3A1 =0.012,respectively).The expression levels of procollagen in the POP group increased following the downregulation of Mfn2.Conclusions:The proliferation rate and cell viability of the fibroblasts in the POP group were significantly lower compared with those in the NPOP group.In the POP fibroblasts,Mfn2 expression was increased,while procollagen expression was decreased. Background:Both Mitofusin 2 (Mfn2) and pelvic organ prolapse (POP) are related to aging.The aim of the present study was to investigate the variations of Mfn2 expression in the uterosacral ligaments of patients with and/or without POP and their correlations with the expression of procollagen.Methods:Fibroblasts were cultured using tissue specimens that were harvested from the uterosacral ligaments of POP and non-POP (NPOP) patients (n =10 for each group) from September 2016 to December 2016.The Cell Counting Kit-8 (CCK-8) assay was used to compare the differences in cell proliferation between the two groups.Relative quantitative reverse transcription-polymerase chain reaction and Western blotting assays were employed to assess the differences in the mRNA and protein expression levels of Mfn2 and procollagen 1A1/1A2/3A1 between the two groups.The changes in procollagen expression were assessed following the downregulation of Mfn2 in the POP group using RNAi.The data were assessed with independent sample t-test or general linear model univariate analysis using the SPSS 13.0 software.Results:The results from CCK-8 assay indicated that cell viability in the POP group was significantly lower compared with that of the NPOP group (td5,7,9,11=-5.925,-6.851,-9.129,and-9.661,respectively,all P 〈 0.001,from D5 to D 11).The mRNA and protein expression levels of Mfn2 in the cultured fibroblasts of the POP group were significantly higher compared with those of the NPOP group (mRNA:t =2.425,P =0.032;protein:t =2.392,P =0.037,respectively),whereas only the expression levels of procollagen 1A1/1A2/3A1 were significantly higher in the NPOP group (mRNA:t =-2.165,P1A1 =0.041;t =-2.741,P1A2 =0.026;t =-2.147,P3A1 =0.045,respectively;protein:t =-2.418,P1A1 =0.029;t =-2.405,P1A2 =0.033;t =-2.470,P3A1 =0.012,respectively).The expression levels of procollagen in the POP group increased following the downregulation of Mfn2.Conclusions:The proliferation rate and cell viability of the fibroblasts in the POP group were significantly lower compared with those in the NPOP group.In the POP fibroblasts,Mfn2 expression was increased,while procollagen expression was decreased.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第24期2951-2959,共9页 中华医学杂志(英文版)
基金 This work was supported by a grant from the National Natural Science Foundation of China (No. 81401185).
关键词 Cell Culture Mitofusin 2 Pelvic Organ Prolapse Procotlagen Cell Culture Mitofusin 2 Pelvic Organ Prolapse Procotlagen
  • 相关文献

参考文献2

二级参考文献24

  • 1王智凤,柯美云,孙晓红,郭晓峰,方秀才.功能性便秘患者肛门直肠动力学和感觉功能测定及其临床意义[J].中华消化杂志,2004,24(9):526-529. 被引量:25
  • 2Hendrix SL, Clark A, Nygaard 1, Aragaki A, Bamabei V, McTieman A. Pelvic organ prolapse in the Pelvic Floor Impact Questionnaire Short Form: gravity and gravidity. Am J Obstet Gynecol 2002,186:1160-6.
  • 3Hui SY, Chan SC, Lam SY, Lau TK, Chung KH. A prospective study on the prevalence of hydronephrosis in women with pelvic organ prolapse and their outcomes after treatment, lnt Urogynecol J 2011 ,22:1529-34.
  • 4Chan SS, Cheung RY, Yiu KW, Lee LL, Pang AW, Chung TK. Symptoms, quality of life, and factors affecting women's treatment decisions regarding pelvic organ prolapse. Int Urogynecol J 2012,23:1027-33.
  • 5Murphy M, Holzberg A, van Raalte H, Kohli N, Goldman HB, Lucente V, et aL Time to rethink: An evidence-based response from pelvic surgeons to the FDA Safety Communication: "UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse". Int Urogynecol J 2012,23:5-9.
  • 6Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW, Deprest J, et al. An International Urogynecological Association (lUGA)/lnternational Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery, lnt Urogynecol .I 2011 ,22:3-15.
  • 7Carey M, Slack M, Higgs P, Wynn-Williams M, Cornish A. Vaginal surgery for pelvic organ prolapse using mesh and a vaginal support device. B JOG 2008,115:391-7.
  • 8Reisenauer C, Shiozawa 1", Huebner M, Slack M, Carey ME Anatomic study of prolapse surgery with nonanchored mesh and a vaginal support device. Am J Obstet Gynecol 2010,203:590.el-7.
  • 9Zyczynski HM, Carey MP, Smith AR, Gauld JM, Robinson D, Sikirica V, et al. One-year clinical outcomes after prolapse surgery with nonanchored mesh and vaginal support device. Am J Obstet Gynecol 2010,203:587.e 1-8.
  • 10Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996,175:10-7.

共引文献5

同被引文献26

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部